Brief: Evofem - On June 8, Co Received Notice From Nasdaq That Co Would Be Permitted To Continue Listing On Nasdaq Through Aug 22 To Regain Compliance
14/06/2022 22:25
June 14 (Reuters) - Evofem Biosciences Inc EVFM.O :
* EVOFEM - ON JUNE 8, 2022 CO RECEIVED NOTICE FROM NASDAQ
THAT CO
WOULD BE PERMITTED TO CONTINUE LISTING ON NASDAQ THROUGH AUG 22
TO REGAIN COMPLIANCE
Further company coverage: EVFM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting